Waystar Holding/$WAY
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Waystar Holding
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
- Ticker
- $WAY
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 1,700
- Headquarters
- Lehi, United States
- Website
- www.waystar.com
Waystar Holding Metrics
BasicAdvanced
$5.2B
38.17
$0.70
0.07
-
Price and volume
Market cap
$5.2B
Beta
0.07
52-week high
$40.35
52-week low
$17.26
Average daily volume
2M
Financial strength
Current ratio
1.847
Quick ratio
1.596
Long term debt to equity
0.367
Total debt to equity
0.372
Interest coverage (TTM)
3.60%
Profitability
EBITDA (TTM)
434.007
Gross margin (TTM)
69.11%
Net profit margin (TTM)
11.18%
Operating margin (TTM)
24.09%
Effective tax rate (TTM)
30.91%
Revenue per employee (TTM)
$710,000
Management effectiveness
Return on assets (TTM)
3.44%
Return on equity (TTM)
3.77%
Valuation
Price to earnings (TTM)
38.166
Price to revenue (TTM)
4.18
Price to book
1.29
Price to tangible book (TTM)
-4.04
Price to free cash flow (TTM)
20.464
Free cash flow yield (TTM)
4.89%
Free cash flow per share (TTM)
1.313
Growth
Revenue change (TTM)
19.23%
Earnings per share change (TTM)
45.53%
3-year revenue growth (CAGR)
17.30%
3-year earnings per share growth (CAGR)
21.26%
What the Analysts think about Waystar Holding
Analyst ratings (Buy, Hold, Sell) for Waystar Holding stock.
Analyst projections of the future price of Waystar Holding stock.
Bulls say / Bears say
Q2 revenue rose 18% year on year and adjusted EBITDA margin was 43%; Waystar also raised its 2026 revenue and EBITDA guidance. This points to strong growth alongside high profitability. (Waystar)
Net revenue retention was 108%, and the number of clients generating more than $100,000 in annual revenue grew 15%. That suggests existing customers are expanding their use of the platform, supporting a durable revenue base. (Waystar)
Waystar’s new AI agents can automatically resubmit eligible rejected claims and help automate clinical documentation reviews. These tools could deepen customer value and create scope to sell more services across its large installed base. (Waystar)
Volume-based revenue grew just 3% year on year in Q2, well below the 34% rise in subscription revenue. That leaves transaction-linked revenue as a relatively slow-growing part of the business. (Waystar)
Waystar had $1.5 billion of gross debt and net leverage of 2.5 times at the end of Q2. That debt could limit financial flexibility if growth or cash generation weakens. (The Motley Fool)
Investors have worried that advances in AI could disrupt software businesses, and Waystar’s shares had fallen 24% in 2026 by mid-September. Continued doubts about AI’s impact could weigh on its valuation despite recent operating growth. (Fierce Healthcare)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2026.
Waystar Holding Financial Performance
Revenues and expenses
Waystar Holding Earnings Performance
Company profitability
Upcoming events
No upcoming events
Waystar Holding News
AllArticlesVideos
Funds containing Waystar Holding
AllUSDGBPEUR
Fund name | Fund size | $WAY weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.18% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.18% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.10% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.10% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.